Shuichan XU

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...
- Patent number 11,873,283
- Issue date Jan 16, 2024
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 11,590,139
- Issue date Feb 28, 2023
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cereblon-based heterodimerizable chimeric antigen receptors
- Patent number 11,331,380
- Issue date May 17, 2022
- Celgene Corporation
- Shuichan Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...
- Patent number 11,325,889
- Issue date May 10, 2022
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer with TOR kinase inhibitors
- Patent number 11,166,950
- Issue date Nov 9, 2021
- Signal Pharmaceuticals, LLC
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...
- Patent number 11,149,007
- Issue date Oct 19, 2021
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,940,152
- Issue date Mar 9, 2021
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,646,493
- Issue date May 12, 2020
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,576,085
- Issue date Mar 3, 2020
- Signal Pharmaceuticals, LLC
- John F. Boylan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer using TOR kinase inhibitor combination...
- Patent number 10,004,735
- Issue date Jun 26, 2018
- Signal Pharmaceuticals, LLC
- Kimberly Elizabeth Fultz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with dihydropyrazino-pyrazines
- Patent number 9,980,963
- Issue date May 29, 2018
- Signal Pharmaceuticals, LLC
- Heather Raymon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with TOR kinase inhibitors
- Patent number 9,937,170
- Issue date Apr 10, 2018
- Signal Pharmaceuticals, LLC
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,795,607
- Issue date Oct 24, 2017
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 9,737,541
- Issue date Aug 22, 2017
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer using TOR kinase inhibitor combination...
- Patent number 9,737,535
- Issue date Aug 22, 2017
- Signal Pharmaceuticals, LLC
- Kimberly Elizabeth Fultz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating a cancer using substituted pyrrolopyrimidine co...
- Patent number 9,623,028
- Issue date Apr 18, 2017
- Signal Pharmaceuticals, LLC
- Dan Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...
- Patent number 9,557,338
- Issue date Jan 31, 2017
- Signal Pharmaceuticals, LLC
- Weiming Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Identification of LKB1 mutation as a predictive biomarker for sensi...
- Patent number 9,555,033
- Issue date Jan 31, 2017
- Signal Pharmaceuticals, LLC
- Rajesh Chopra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 9,512,124
- Issue date Dec 6, 2016
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer with dihydropyrazino-pyrazines
- Patent number 9,505,764
- Issue date Nov 29, 2016
- Signal Pharmaceuticals, LLC
- Heather Raymon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with TOR kinase inhibitors
- Patent number 9,493,466
- Issue date Nov 15, 2016
- Signal Pharmaceuticals, LLC
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,428,509
- Issue date Aug 30, 2016
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating advanced non-small cell lung cancer (NSCLC) by...
- Patent number 9,375,443
- Issue date Jun 28, 2016
- Signal Pharmaceuticals, LLC
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,346,812
- Issue date May 24, 2016
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...
- Patent number 9,155,736
- Issue date Oct 13, 2015
- Signal Pharmaceuticals, LLC
- Weiming Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...
- Publication number 20240368083
- Publication date Nov 7, 2024
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of Cancer with TOR Kinase Inhibitors
- Publication number 20230338370
- Publication date Oct 26, 2023
- Signal Pharmaceuticals, LLC.
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20230158035
- Publication date May 25, 2023
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...
- Publication number 20230002321
- Publication date Jan 5, 2023
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS
- Publication number 20220370580
- Publication date Nov 24, 2022
- Celgene Corporation
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
- Publication number 20220273650
- Publication date Sep 1, 2022
- Signal Pharmaceuticals, LLC.
- SHUICHAN XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20210128565
- Publication date May 6, 2021
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20200237768
- Publication date Jul 30, 2020
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...
- Publication number 20200199074
- Publication date Jun 25, 2020
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...
- Publication number 20200199073
- Publication date Jun 25, 2020
- Celgene Corporation
- Massimo Ammirante
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20190336507
- Publication date Nov 7, 2019
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS
- Publication number 20190240304
- Publication date Aug 8, 2019
- Celgene Corporation
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
- Publication number 20180235960
- Publication date Aug 23, 2018
- Signal Pharmaceuticals, LLC.
- Shuichan XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...
- Publication number 20170312278
- Publication date Nov 2, 2017
- Signal Pharmaceuticals, LLC.
- Kimberly Elizabeth FULTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20170281633
- Publication date Oct 5, 2017
- Signal Pharmaceuticals, LLC.
- John F. Boylan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...
- Publication number 20170173024
- Publication date Jun 22, 2017
- Signal Pharmaceuticals, LLC.
- Dan ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES
- Publication number 20170065583
- Publication date Mar 9, 2017
- Signal Pharmaceuticals, LLC.
- HEATHER RAYMON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20170042902
- Publication date Feb 16, 2017
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
- Publication number 20170027932
- Publication date Feb 2, 2017
- Signal Pharmaceuticals, LLC.
- Shuichan XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20160324861
- Publication date Nov 10, 2016
- Signal Pharmaceutical, LLC
- Andrew Antony Calabrese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20160096841
- Publication date Apr 7, 2016
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...
- Publication number 20160008365
- Publication date Jan 14, 2016
- Signal Pharmaceuticals, LLC.
- Dan ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...
- Publication number 20150362505
- Publication date Dec 17, 2015
- Signal Pharmaceuticals, LLC.
- Weiming Xu
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...
- Publication number 20150297590
- Publication date Oct 22, 2015
- Signal Pharmaceuticals, LLC.
- Kimberly Elizabeth FULTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER CHARACTERIZED BY GENE MUTATIONS
- Publication number 20150099754
- Publication date Apr 9, 2015
- Signal Pharmaceuticals, LLC.
- Shuichan Xu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES
- Publication number 20140314673
- Publication date Oct 23, 2014
- Signal Pharmaceuticals, LLC.
- HEATHER RAYMON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES
- Publication number 20140315907
- Publication date Oct 23, 2014
- Signal Pharmaceuticals, LLC.
- HEATHER RAYMON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...
- Publication number 20140113905
- Publication date Apr 24, 2014
- Signal Pharmaceuticals, LLC.
- Weiming Xu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
- Publication number 20130245026
- Publication date Sep 19, 2013
- Signal Pharmaceuticals, LLC.
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
- Publication number 20130245029
- Publication date Sep 19, 2013
- Signal Pharmaceuticals, LLC.
- Shuichan Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Shuichan XU

Person

Patents Grantslast 30 patents

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...

Substituted aminopurine compounds, compositions thereof, and method...

Cereblon-based heterodimerizable chimeric antigen receptors

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...

Treatment of cancer with TOR kinase inhibitors

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds,...

Substituted aminopurine compounds, compositions thereof, and method...

Substituted aminopurine compounds, compositions thereof, and method...

Substituted aminopurine compounds, compositions thereof, and method...

Methods for treating cancer using TOR kinase inhibitor combination...

Treatment of cancer with dihydropyrazino-pyrazines

Treatment of cancer with TOR kinase inhibitors

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Substituted aminopurine compounds, compositions thereof, and method...

Methods for treating cancer using TOR kinase inhibitor combination...

Methods of treating a cancer using substituted pyrrolopyrimidine co...

Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...

Identification of LKB1 mutation as a predictive biomarker for sensi...

Substituted aminopurine compounds, compositions thereof, and method...

Treatment of cancer with dihydropyrazino-pyrazines

Treatment of cancer with TOR kinase inhibitors

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Method for treating advanced non-small cell lung cancer (NSCLC) by...

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...

Patents Applicationslast 30 patents

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...

Treatment of Cancer with TOR Kinase Inhibitors

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...

CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS,...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS

METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...

TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...

INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...

METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...

TREATMENT OF CANCER CHARACTERIZED BY GENE MUTATIONS

TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES

TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES

INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS